patient tested positive to COVID-19/nasopharyngitis, cough and sneezing and influenza; on 3May2022 patient tested positive to COVID-19; itchy circle in left arm; little red circle in left arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy circle in left arm), ERYTHEMA (little red circle in left arm), COVID-19 (patient tested positive to COVID-19/nasopharyngitis, cough and sneezing and influenza) and DRUG INEFFECTIVE (on 3May2022 patient tested positive to COVID-19) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 035C21A, 040A21A and 016M20A) for COVID-19 vaccination.     Allergies to medications, food and other products were reported as no. History relating to mentioned adverse events and both Acute and Chronic illnesses at the time of vaccination was reported as no.  Concurrent medical conditions included Blood pressure high. Concomitant products included LISINOPRIL for Blood pressure high, DULOXETINE for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, the patient experienced PRURITUS (itchy circle in left arm) and ERYTHEMA (little red circle in left arm). On 03-May-2022, the patient experienced COVID-19 (patient tested positive to COVID-19/nasopharyngitis, cough and sneezing and influenza) and DRUG INEFFECTIVE (on 3May2022 patient tested positive to COVID-19). On 06-Nov-2021, PRURITUS (itchy circle in left arm) and ERYTHEMA (little red circle in left arm) had resolved. At the time of the report, COVID-19 (patient tested positive to COVID-19/nasopharyngitis, cough and sneezing and influenza) had resolved with sequelae and DRUG INEFFECTIVE (on 3May2022 patient tested positive to COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-May-2022, SARS-CoV-2 test: positive (Positive) Positive.         The residual effects were reported as  occasional cough and sneeze. Patient treated flu symptoms with cold and cough medicine and  did not remember the name. Company comment This is a spontaneous case concerning 73-year-old female patient with no relevant medical history reported, who experienced the non-serious, unexpected event of COVID-19, among others, which occurred 9 months and 22 days after the 3rd dose of mRNA-1273. The 1st and 2nd doses are received in an appropriate schedule. Drug ineffective was considered an additional event. It was reported that after 1st dose and 1st booster shot, patient only experienced a little red and itchy circle in her left arm for a couple of days. Then, cold symptoms. The symptoms are improving with residual effects, like occasional cough and sneeze. The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to MOD-2022-559312 (Patient Link).; Sender's Comments: This is a spontaneous case concerning 73-year-old female patient with no relevant medical history reported, who experienced the non-serious, unexpected event of COVID-19, among others, which occurred 9 months and 22 days after the 3rd dose of mRNA-1273. The 1st and 2nd doses are received in an appropriate schedule. Drug ineffective was considered an additional event. It was reported that after 1st dose and 1st booster shot, patient only experienced a little red and itchy circle in her left arm for a couple of days. Then, cold symptoms. The symptoms are improving with residual effects, like occasional cough and sneeze. The benefit-risk relationship of mRNA-1273 is not affected by this report.